Acupuncture for Recovery and Postoperative Nausea and Vomiting After Middle Ear Surgeries

Sponsor
Zagazig University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04748133
Collaborator
(none)
59
1
2
4.3
13.7

Study Details

Study Description

Brief Summary

Modern surgery management needs increasing operating room turnover and more ambulatory surgery. In order to come over this challenge, the recovery needs to be optimized. Enhancing recovery could be achieved by preventing postoperative pain and postoperative nausea and vomiting. Middle ear surgery is a common ambulatory surgery with increasing occurrence of postoperative nausea and vomiting.

Condition or Disease Intervention/Treatment Phase
  • Device: acupuncture needles
  • Other: placebo
N/A

Detailed Description

Sample size: as percent of vomiting following acupuncture and following standard anesthesia is 0.13% and 29.2% respectively so sample size is 58 (29 in each group). Sample is calculated using open epi program with confidence level 95% and power 80%.

Patients in Group C (control group) (n=29): will receive no treatment. While patients in Group A (Acupuncture group) (n=29): will receive needle acupuncture.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
59 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Acupuncture for Enhancing Recovery and Attenuating Postoperative Nausea and Vomiting After Middle Ear Surgeries: A Randomized Controlled Trial
Actual Study Start Date :
Feb 20, 2021
Anticipated Primary Completion Date :
Jun 1, 2021
Anticipated Study Completion Date :
Jul 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: acupuncture

Patients in the acupuncture group will receive a standardised treatment with 12 needles (sharp tip, stainless steel needles, size 0.3 X 40 mm) at 7 acupuncture points Du 26 and Ren 17 (on the middle body line), and bilateral LI 4, HE 7, LV 3, ST 36 and PC 6). Application of the needles is performed by a licensed medical acupuncturist. The needles will be inserted after endotracheal intubation and mechanical ventilation and will be removed immediately before patient extubation.

Device: acupuncture needles
Site of acupuncture points: Du 26: At junction of the upper and middle third of philtrum. Ren 17: On the midline level with the 4th intercostal space midway between the nipples. LI4 (Large Intestine 4): On the dorsum of the hand, between the 1st and 2nd metacarpal bones HT7 (Heart 7): On the ulnar end of the transverse crease of the wrist, in the small depression between the pisiform and ulna bones LV3 (Liver 3): On dorsum of the foot in a depression distal to the junction of the 1st and 2nd metatarsal bones. ST36 (Stomach 36): Antero-lateral leg, 1 middle-finger breadth next to the anterior crest of tibia, 3 cun under the depression lateral to the patellar ligament. PC6 (Pericardium 6): Palmar aspect of the forearm, between the tendons, 2 cun away from the transverse crease of the wrist

Placebo Comparator: placebo

no treatment

Other: placebo
no treatment

Outcome Measures

Primary Outcome Measures

  1. incidence of postoperative nausea and vomiting [up to 24 hours postoperative]

    Postoperative nausea and vomiting impact scale score . Questions Answers score Did you have vomiting or dry retching? No 0 Once 1 Twice 2 Three or more times 3 Have you experienced a feeling of nausea? If yes, has it interfered with your daily activities? Not at all 0 Sometimes 1 Often/most of the times 2 All the time 3 Summation of numerical answer to question 1 plus 2 equal the PONV impact scale. PONV Impact Scale Score of ≥5 represents clinically important PONV

Secondary Outcome Measures

  1. extubation time [up to 10 minutes postoperative]

    time from discontinuation of isoflurane to extubation

  2. recovery time [up to 30 minutes postoperative]

    time from discontinuation of isoflurane to first response to verbal command

  3. The time of discharge [up to 30 minutes postoperative]

    The time from arrival to PACU to discharge to the ward) according to Modified Aldert score Modified Aldert score . Assessment item Condition Grade Activity, able to move, voluntarily or on command 4 extremities 2 2 extremities 1 No 0 Breathing Able to breathe deeply & cough freely 2 Dyspnea, shallow or limited breathing 1 Apnea 0 Consciousness Fully awake 2 Arousable on calling 1 Unresponsive 0 Circulation (blood pressure) ±20% of pre-anesthesia level 2 20% to 49% of pre-anesthesia level 1 50% of pre-anesthesia level 0 SPO2 Maintain SPO2 >92% in ambient air 2 Maintain SPO2 >90% with O2 1 Maintain SPO2 <90% with O2 0 Patient having a score of 9 or higher is discharged

  4. The total number of rescue antiemetic (metoclopramide) [in the first 24 hour postoperative]

    Any patient will receive 10 mg intravenous metoclopramide immediately if there is nausea and vomiting

  5. Postoperative Pain [up to 30 minutes, 2 hours and 4 hours postoperative]

    Visual Analogue Scale (VAS) . A commonly used scale is a 10-cm line labeled with "worst pain imaginable" on the right border and "no pain" on the left border. The patient is instructed to make a mark along the line to represent the intensity of pain currently being experienced. IV paracetamol 1 gm every 6hs as a protocol for pain management and IV pethidine 30 mg as rescue analgesic will be given if VAS ≥ 4. Total doses and number of analgesics will be recorded

  6. number of participant with side effects of acupuncture [up to 24 hours postoperative]

    bleeding, soreness, or bruising at the site of needle insertion

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Written informed consent from the patient.

  • Age: 21-60 years old.

  • Sex: both sex (males or females).

  • Physical status: ASA 1& II.

  • BMI = (20-30 kg/m2).

  • Type of operations: elective unilateral middle ear surgeries such as tempanoplasty, stapedectomy and mastedictomy.

Exclusion Criteria:
  • Altered mental state

  • Patients with Drug abuse or alcohol.

  • Patients with on antipsychotic drugs, regular antiemetic therapy or receiving antiemetic 24 hour before surgery.

  • Patients with pre-treatment with acupuncture or trigger point injection.

  • Pregnancy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zagazig University Zagazig Egypt

Sponsors and Collaborators

  • Zagazig University

Investigators

  • Principal Investigator: Marwa Zakzouk, MD, Zagazig University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marwa Mahmoud Abd Allah Zakzouk, Lecturer of Anesthesia & Surgical Intensive Care, Zagazig University, Zagazig University
ClinicalTrials.gov Identifier:
NCT04748133
Other Study ID Numbers:
  • 6658
First Posted:
Feb 10, 2021
Last Update Posted:
Feb 24, 2021
Last Verified:
Feb 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 24, 2021